Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
As quantum tech hits the investing stage, two very different bets stand out: IonQ Quantum Computing Inc. and Quantum ...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Nvidia’s shares lag the broader chip rally even as demand for AI accelerates, prompting questions about earnings timi...
Quantum computing stocks IonQ and D-Wave have drawn big attention after a steep rally. This guide breaks down what ha...
NVIDIA has slipped about 17% from its May high, leaving investors debating whether the AI powerhouse is finally a bar...
Investing in semiconductors means weighing two heavyweight names: Intel and TSMC. This guide breaks down the landscap...
Choosing between VYM and VIG comes down to income now vs. growth later. This guide breaks down how each ETF targets d...
Inflation trends keep shifting, and the fed's latest inflation forecast is a key signal for investors. This guide bre...
As AI expands data center demand, Micron sits at the center of memory supply. This guide breaks down the odds for 202...
The Federal Reserve’s newest inflation outlook suggests a higher-for-longer rate path, but investors are cautiously u...